The prevalence of chronic obstructive pulmonary disease in Elazig, Eastern Turkey

European Journal of Internal Medicine

Volumn 22, Issue 2, 2011, Pages 172-176

  Deveci, Figen ^a   Deveci, S Erhan ^a   Türkoǧlu, Suat ^a   Turgut, Teyfik ^a   Kirkil, Gamze ^a   Rahman, Süheyla ^a   Açik, Yasemin ^a   Muz, M Hamdi ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Chronic obstructive pulmonary disease; Prevalence; Risk factors

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL FEATURE; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAL ERROR; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; RURAL AREA; SPIROMETRY; TURKEY (REPUBLIC); URBAN AREA;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POVERTY; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RISK FACTORS; RURAL POPULATION; SEX FACTORS; SMOKING; SPIROMETRY; TURKEY; URBAN POPULATION; YOUNG ADULT;

EID: 79952702542     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.12.014     Document Type: Article

References (34)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55. (Pubitemid 47403272)
2. Dennis RJ, Maldonado D, Norman S, Baena E, Martinez G. Wood smoke exposure and risk for obstructive airways disease among women. Chest 1996;109:115-9. (Pubitemid 26017605)
3. Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001;68:4-19. (Pubitemid 32172948)
4. Özer U, Aydin R, Akçay H. Air pollution profile of Turkey. Chem Int 1997;19:190-1.
5. Murray CJ, Lopez AD. Evidence-based health policy - lessons from the global burden of disease study. Science 1996;274:740-3. (Pubitemid 26398244)
6. Murray CJL, Lopez AD, editors. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA: Harward University Press; 1996.
7. Lange P, Groth S, Nyboe J, Appleyard M, Mortensen J, Jensen G, et al. Chronic obstructive lung disease in Copenhagen: cross-sectional epidemiological aspects. J Intern Med 1989;226:25-32. (Pubitemid 19182417)
8. Bakke PS, Baste V, Hanoa R, Gulsvik A. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax 1991;46:863-70.
9. Sobradillo V, Miravitlles M, Jimenez CA, Gabriel R, Viejo JL, Masa JF, et al. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation. Arch Bronconeumol 1999;35:159-66.
10. Menezes AM, Victora CG, Rigatto M. Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: a population-based study. Thorax 1994;49:1217-21.
11. Kim DS, Kim YS, Jung KS, Chang JH, Lim CM, Lee JH, et al. Korean Academy of Tuberculosis and Respiratory Diseases. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005;172:842-7. (Pubitemid 41369067)
12. Minas M, Hatzoglou C, Karetsi E, Papaioannou AI, Tanou K, Tsaroucha R, et al. COPD prevalence and the differences between newly and previously diagnosed COPD patients in a spirometry program. Prim Care Respir J 2010 Jun 7.pii: pcrj-2009-07-0060-R2. doi: 10.4104/pcrj.2010.00034 (Ebup ahead of print).
13. Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC, Pehlivan E. Prevalence of COPD: first epidemiological study of a large region in Turkey. Eur J Intern Med 2008;19:499-504.
14. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50.
15. Kiraz K, Kart L, Demir R, Oymak S, Gulmez I, Unalacak M, et al. Chronic pulmonary disease in rural women exposed to biomass fumes. Clin Invest Med 2003;26:243-8. (Pubitemid 37463933)
16. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003;123:1684-92.
17. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000;160:1683-9.
18. Viegi G, Pedreschi M, Pistelli F, Di Pede F, Baldacci S, Carrozzi L, et al. Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest 2000;117(5 suppl 2):339-45.
19. Lamprecht B, Schirnhofer L, Kaiser B, Studnicka M, Buist AS. Farming and the prevalence of non-reversible airways obstruction-results from a population-based study. Am J Ind Med 2007;50:421-6. (Pubitemid 46883934)
20. Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, Menezes AM, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005;2:277-83. (Pubitemid 40993302)
21. ATS/ERS Task Force: standardisation of lung function testing - standardisation of spirometry. Eur Respir J 2005;26:319-38.
22. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardized lung function testing. European Community for Steel and Coal, Official Statement of the European Respiratory Society. Eur Respir J 1993;6(suppl 16):5-40.
23. Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 2004;9:458-65. (Pubitemid 40179750)
24. Lundback B, Lindberg A, Lindström M, Rönmark E, Jonsson AC, Jönsson E, et al. Obstructive Lung Disease in Northern Sweden Studies. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003;97:115-22.
25. Benediktsdottir B, Gudmundsson G, Jörundsdottir KB, Vollmer W, Gislason T. Prevalence of COPD in Iceland - the BOLD study. Laeknabladid 2007;93:471-7.
26. Tatsumi K. Epidemiological survey of chronic obstructive pulmonary disease in Japan. Respirology 2001;6(suppl):27-33.
27. Seyama K. State of alpha1-antitrypsin deficiency in Japan. Respirology 2001;6 (suppl):35-8.
28. Nizankowska-Mogilnicka E, Mejza F, Buist AS, Vollmer WM, Skucha W, Harat R, et al. Prevalence of COPD and tobacco smoking in Malopolska region - results from the BOLD Study in Poland. Pol Arch Med Wewn 2007;117:402-10. (Pubitemid 350190345)
29. Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007;176:753-60. (Pubitemid 47598476)
30. Hardie JA, Vollmer WM, Buist AS, Bakke P, Morkve O. Respiratory symptoms and obstructive pulmonary disease in a population aged over 70 years. Respir Med 2005;99:186-95. (Pubitemid 40104273)
31. Prescott E, Vestbo J. Socioeconomic status and chronic obstructive pulmonary disease. Thorax 1999;54:737-41. (Pubitemid 29341412)
32. Bakke PS, Hanoa R, Gulsvik A. Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: a Norwegian community study. Am J Epidemiol 1995;141:1080-8.
33. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006;61:935-9. (Pubitemid 44787161)
34. Pena VS, Miravitlles M, Gabriel R, Jimenez-Ruiz CA, Villasante C, Masa JF, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000;118:981-9.